Minapharm Pharmaceuticals SAE operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Minapharm Pharmaceuticals SAE with three other
pharmaceutical manufacturers in Middle East:
Gulf Pharmaceutical Industries
of UNITED ARAB EMIRATES
sales of 301.50 million UAE Dirham [US$82.09 million]
of which 100%
Arab Drug Company for Pharmaceuticals and Chemical Industries SAE
(436.35 million Egyptian Pounds [US$27.17 million]
Kahira Pharmaceuticals and Chemical Industries Co
(962.94 million Egyptian Pounds [US$59.96 million]
Minapharm Pharmaceuticals SAE reported sales of 2.05 billion Egyptian Pounds (US$127.72 million)
December of 2019.
increase of 6.9%
versus 2018, when the company's sales were 1.92 billion Egyptian Pounds.
Sales at Minapharm Pharmaceuticals SAE have increased during each of the previous five years
(and since 2014, sales have increased a total of 147%).